English
Home > Products > CAS NO 74784-70-6

China CAS NO 74784-70-6 Factory

We insist on offering high-quality creation with superior business enterprise concept, honest revenue plus the greatest and fast service. it will bring you not only the high quality solution and huge profit, but essentially the most significant is usually to occupy the endless market for CAS NO 74784-70-6,74784-70-6,5-(Trifluoromethyl)pyridin-2-amine, Therefore, we are able to meet up with different inquiries from different purchasers. Remember to discover our website to check a lot more information from our products.
CAS NO 74784-70-6, We severely promise that we give all the customers with the best quality products and solutions, the most competitive prices and the most prompt delivery. We hope to win a resplendent future for customers and ourselves.

Related Products

Hot Products

  • Deflazacort

    Deflazacort

    Product Name:Deflazacort
    Molecular Formula:C25H31NO6
    Molecular Weight:441.52
    CAS Registry Number;14484-47-0
  • Arabinoguanosine

    Arabinoguanosine

    Product Name:Arabinoguanosine
    Molecular Formula:C10H13N5O5
    Molecular Weight:283.24
    CAS Registry Number:38819-10-2
  • Ammonium sulfate

    Ammonium sulfate

    Product Name:Ammonium sulfate
    Molecular Formula:H8N2O4S
    Molecular Weight:132.14
    CAS Registry Number:7783-20-2
  • Regorafenib hydrate

    Regorafenib hydrate

    Product Name:Regorafenib hydrate
    Molecular Formula:C21H17ClF4N4O4
    Molecular Weight;500.83
    CAS Registry Number;1019206-88-2
  • Fmoc-L-Lys[C20-OtBu-Glu(OtBu)-AEEA-AEEA]-OH

    Fmoc-L-Lys[C20-OtBu-Glu(OtBu)-AEEA-AEEA]-OH

    Product Name:Fmoc-L-Lys[C20-OtBu-Glu(OtBu)-AEEA-AEEA]-OH
    Molecular Formula:C66H105N5O16
    Molecular Weight:1224.59
    CAS Registry Number:2460751-66-8
  • 1,4-Dihydro-2,6-dimethyl-4-(2',3'-dichlorophenyl)-5-carboxy methyl-3-pyridinecarboxylic acid

    1,4-Dihydro-2,6-dimethyl-4-(2',3'-dichlorophenyl)-5-carboxy methyl-3-pyridinecarboxylic acid

    Product Name:1,4-Dihydro-2,6-dimethyl-4-(2',3'-dichlorophenyl)-5-carboxy methyl-3-pyridinecarboxylic acid
    Molecular Formula:C16H15Cl2NO4
    Molecular Weight:356.2
    CAS Registry Number:123853-39-4
  • Related Blog
  • Reviews

  • Everything You Need To Know About Active Pharmaceutical Ingredients (API In Pharma)

    Sandoo, as a professional API manufactruer in China, we produces a wide range of active pharmaceutical ingredients which can be used in the production of medicines in different applications. Our products are produced under strict procedures and cGMP (Current Good Manufacturing Practices). In addtion, we can also customize new pharmaceutical compounds for new drugs.

  • Why API manufacturing companies almostly in China?

    In the chemical API industry, developed countries such as the United States and Europe occupy a dominant position in the field of patented APIs with high added value by virtue of their advantages in research and development, production technology, and intellectual property protection...

  • What are the raw materials required for pharmaceutical industry?

    Pharmaceutical industry has a lot of constraints and specialties which make it stand on a completely differents scale than any other industries. Being closely related to the medical field and also complementary to it, the pharmaceutical industry needs utmost care and precision in each and every aspect of the field ranging from collecting the raw materials to getting the final product ready for supply in the market.

  • CAS No. 144689-24-7 Olmesartan Introduction

    Olmesartan is an angiotensin II receptor blocker, widely used for the treatment of hypertension. The Renin-Angiotensin-Aldosterone System (RAAS) plays an importent role in the development and progression of many diseases such as hypertension...

  • What is Coenzyme Q10 CAS NO.303-98-0

    Coenzyme Q10 (CAS NO.303-98-0 ) is a fat-soluble antioxidant, which can activate the nutrition of human cells and cellular energy, and has the functions of improving human immunity, enhancing antioxidation, delaying ageing and enhancing human vitality.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept